Differential effects of priming with DNA vaccines encoding the hemagglutinin and/or fusion proteins on cytokine responses after measles virus challenge

Fernando P. Polack, Scott J. Hoffman, William J Moss, Diane Griffin

Research output: Contribution to journalArticle

Abstract

Measles is associated with a million deaths a year in developing countries because of secondary infections. Morbidity is particularly severe in young infants. Both measles-induced immune suppression and atypical measles have been associated with a type 2 cytokine bias of the immune response. The role of individual virus proteins in the induction of these cytokine responses is unknown and could be important for the development of new vaccines. We have used a rhesus macaque model and DNA vaccines to investigate cytokine responses to the individual measles virus (MV) protective antigens, hemagglutinin and fusion. The hemagglutinin protein primed for a type 2 cytokine response, with suppression of interleukin (IL)-12 and preferential production of IL-4 after MV challenge. The fusion protein primed for a type 1 response with preferential production of interferon-γ. Responses were modulated when both proteins were used for priming. Therefore, the specific proteins included in a new measles vaccine will affect the type of cytokine response elicited.

Original languageEnglish (US)
Pages (from-to)1794-1800
Number of pages7
JournalJournal of Infectious Diseases
Volume187
Issue number11
DOIs
StatePublished - Jun 1 2003

Fingerprint

Measles virus
DNA Vaccines
Hemagglutinins
Cytokines
Measles
Proteins
Measles Vaccine
Interleukin-12
Macaca mulatta
Coinfection
Interleukin-4
Interferons
Developing Countries
Vaccines
Viruses
Morbidity
Antigens

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Differential effects of priming with DNA vaccines encoding the hemagglutinin and/or fusion proteins on cytokine responses after measles virus challenge. / Polack, Fernando P.; Hoffman, Scott J.; Moss, William J; Griffin, Diane.

In: Journal of Infectious Diseases, Vol. 187, No. 11, 01.06.2003, p. 1794-1800.

Research output: Contribution to journalArticle

@article{f00f7a3b68fe4a24af0ebc6096f77446,
title = "Differential effects of priming with DNA vaccines encoding the hemagglutinin and/or fusion proteins on cytokine responses after measles virus challenge",
abstract = "Measles is associated with a million deaths a year in developing countries because of secondary infections. Morbidity is particularly severe in young infants. Both measles-induced immune suppression and atypical measles have been associated with a type 2 cytokine bias of the immune response. The role of individual virus proteins in the induction of these cytokine responses is unknown and could be important for the development of new vaccines. We have used a rhesus macaque model and DNA vaccines to investigate cytokine responses to the individual measles virus (MV) protective antigens, hemagglutinin and fusion. The hemagglutinin protein primed for a type 2 cytokine response, with suppression of interleukin (IL)-12 and preferential production of IL-4 after MV challenge. The fusion protein primed for a type 1 response with preferential production of interferon-γ. Responses were modulated when both proteins were used for priming. Therefore, the specific proteins included in a new measles vaccine will affect the type of cytokine response elicited.",
author = "Polack, {Fernando P.} and Hoffman, {Scott J.} and Moss, {William J} and Diane Griffin",
year = "2003",
month = "6",
day = "1",
doi = "10.1086/375245",
language = "English (US)",
volume = "187",
pages = "1794--1800",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Differential effects of priming with DNA vaccines encoding the hemagglutinin and/or fusion proteins on cytokine responses after measles virus challenge

AU - Polack, Fernando P.

AU - Hoffman, Scott J.

AU - Moss, William J

AU - Griffin, Diane

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Measles is associated with a million deaths a year in developing countries because of secondary infections. Morbidity is particularly severe in young infants. Both measles-induced immune suppression and atypical measles have been associated with a type 2 cytokine bias of the immune response. The role of individual virus proteins in the induction of these cytokine responses is unknown and could be important for the development of new vaccines. We have used a rhesus macaque model and DNA vaccines to investigate cytokine responses to the individual measles virus (MV) protective antigens, hemagglutinin and fusion. The hemagglutinin protein primed for a type 2 cytokine response, with suppression of interleukin (IL)-12 and preferential production of IL-4 after MV challenge. The fusion protein primed for a type 1 response with preferential production of interferon-γ. Responses were modulated when both proteins were used for priming. Therefore, the specific proteins included in a new measles vaccine will affect the type of cytokine response elicited.

AB - Measles is associated with a million deaths a year in developing countries because of secondary infections. Morbidity is particularly severe in young infants. Both measles-induced immune suppression and atypical measles have been associated with a type 2 cytokine bias of the immune response. The role of individual virus proteins in the induction of these cytokine responses is unknown and could be important for the development of new vaccines. We have used a rhesus macaque model and DNA vaccines to investigate cytokine responses to the individual measles virus (MV) protective antigens, hemagglutinin and fusion. The hemagglutinin protein primed for a type 2 cytokine response, with suppression of interleukin (IL)-12 and preferential production of IL-4 after MV challenge. The fusion protein primed for a type 1 response with preferential production of interferon-γ. Responses were modulated when both proteins were used for priming. Therefore, the specific proteins included in a new measles vaccine will affect the type of cytokine response elicited.

UR - http://www.scopus.com/inward/record.url?scp=0038540535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038540535&partnerID=8YFLogxK

U2 - 10.1086/375245

DO - 10.1086/375245

M3 - Article

C2 - 12751038

AN - SCOPUS:0038540535

VL - 187

SP - 1794

EP - 1800

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 11

ER -